AIDA SAMSON: Open Payments
NPI 1770853038 · SARASOTA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,358 in 62 payments from 17 companies in 2025. Trend: 2023 $2,829 · 2024 $3,332 · 2025 $1,358
Food & beverage: $1,358
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 11 | $302 |
| ABBVIE INC. | 11 | $190 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $186 |
| Madrigal Pharmaceuticals | 4 | $123 |
| Aimmune Therapeutics, Inc. | 6 | $114 |
| Ardelyx, Inc. | 3 | $69 |
| Fresenius Kabi USA, LLC | 2 | $57 |
| Ipsen Biopharmaceuticals, Inc | 3 | $56 |
| Phathom Pharmaceuticals, Inc. | 3 | $44 |
| Amgen Inc. | 2 | $41 |
Products named: TREMFYA, REZDIFFRA, RINVOQ, VOWST, ENTYVIO, IBSRELA, EOHILIA, IQIRVO.
Industry payments across FL — which companies pay providers there.
